Squeeze Report — September 29, 2026

Today's top short-squeeze candidates

1. #1ORICOric Pharmaceuticals, Inc. Com83

   The #1 squeeze screen rank is real, but ESMO posters can cut both ways and the borrow fee gives shorts no urgency.

   SI 36%DTC 14.2$13.27+0% 20dHealthcare
2. #2GRPNGroupon, Inc. Common Stock82

   65% of a shrinking float is short, but 250k shares available at 1.4% means no one is forced to cover yet.

   SI 65%DTC 14.3$19.74+1% 20dCommunication Services
3. #3TNGXTango Therapeutics, Inc.81

   39% of float sold short · 18.8 days to cover · +4% over 20 days

   SI 39%DTC 18.8$24.30+4% 20dHealthcare
4. #4NEONeoGenomics, Inc. Common Stock80

   72% of float sold short · 11.2 days to cover · +7% over 20 days

   SI 72%DTC 11.2$19.29+7% 20dHealthcare
5. #5ABSIAbsci Corporation Common Stock79

   Elevated days-to-cover meets a $87.5M open ATM, so any squeeze faces immediate supply from management itself.

   SI 25%DTC 14.4$9.49+9% 20dHealthcare
6. #6VOYGVoyager Technologies, Inc.79

   Two recent convertibles and a prepaid forward add heavy supply, leaving this dependent on a genuine Q3 earnings surprise.

   SI 20%DTC 8.7$33.18-3% 20dIndustrials
7. #7PRCHPorch Group, Inc. Common Stock77

   20% of float sold short · 12.9 days to cover · -3% over 20 days

   SI 20%DTC 12.9$16.83-3% 20dFinancial Services
8. #8ACHCAcadia Healthcare Company, Inc76

   25% of float sold short · 18.8 days to cover · -2% over 20 days

   SI 25%DTC 18.8$27.91-2% 20dHealthcare
9. #9PGENPrecigen, Inc. Common Stock76

   27% of float sold short · 16.3 days to cover · +12% over 20 days

   SI 27%DTC 16.3$7.81+12% 20dHealthcare
10. #10VKTXViking Therapeutics, Inc. Comm76

    20% of float sold short · 12.3 days to cover · +3% over 20 days

    SI 20%DTC 12.3$33.03+3% 20dHealthcare
11. #11ARQTArcutis Biotherapeutics, Inc.76

    The February PDUFA and Q4 vitiligo data are real, but the 18% base rate and heavy insider selling keep this medium at best.

    SI 17%DTC 8.5$27.33+15% 20dHealthcare
12. #12HALOHalozyme Therapeutics, Inc. Co75

    13% of float sold short · 11.6 days to cover · +7% over 20 days

    SI 13%DTC 11.6$112.89+7% 20dHealthcare
13. #13SEISolaris Energy Infrastructure,75

    Nine insider buys and a cleared patent overhang fight against two in-the-money converts that can flood supply.

    SI 36%DTC 5.1$69.15+39% 20dEnergy
14. #14SMMTSummit Therapeutics Inc. Commo75

    AstraZeneca's $2B validation removes solvency risk, but the low borrow fee suggests shorts are not trapped into the PDUFA.

    SI 37%DTC 6.6$15.48+13% 20dHealthcare
15. #15MMEDMiniMed Group, Inc. Common Sto74

    The October 9 exchange offer could expand float eightfold, collapsing the very scarcity that makes this a squeeze candidate.

    SI 49%DTC 4.8$20.49+2% 20dHealthcare